AstraZeneca Pharma India on Monday said it has received approval for extended indication from the Drugs Controller General of India for Dapagliflozin 10 mg tablets. The receipt of this permission ...

New Delhi: AstraZeneca Pharma India on Saturday said it has received approval from the Drugs Controller General of India (DCGI) for Dapagliflozin tablets for the treatment of patients with chronic ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announced the results of DERIVE, a Phase 3 study that evaluated the efficacy and safety of FARXIGA ® (dapagliflozin 10 mg), in patients with ...

LONDON (Alliance News) - AstraZeneca (AZN ... The patients treated with dapagliflozin 10 mg as an add-on therapy to metformin plus sulfonylurea, met key secondary endpoint of less than 7 percent ...

Bristol-Myers Squibb and AstraZeneca announced positive results ... mg/dL for dapagliflozin 5 mg and -23.5 mg/dL /dl for dapagliflozin 10 mg, compared to -6.0 mg/dL for placebo.

AstraZeneca) and 10 mg of the SGLT2 inhibitor dapagliflozin (Forxiga/Farxiga, AstraZeneca) for the treatment of type 2 diabetes in adults, according to a news release from AstraZeneca. Qtern is ...

and AstraZeneca (NYSE: AZN) today announced results from a Phase 3 clinical study that showed the investigational compound dapagliflozin 10 mg demonstrated significant reductions in blood sugar ...

and AstraZeneca (NYSE: AZN) today announced results from two 24-week Phase 3 clinical studies examining the investigational compound dapagliflozin at 5 mg or 10 mg (clinical trial dose ...

Lupin has received tentative approval from the Food and Drug Administration for Dapagliflozin and Saxagliptin Tablets, 5 mg/5 mg and 10 mg/5 mg, which is the generic of AstraZeneca’s Qtern.

To assess the efficacy and safety of early dapagliflozin (Farxiga, AstraZeneca ... were randomly assigned to dapagliflozin 10 mg once daily or structured usual care with protocolized diuretic ...

After that, Heerspink's group only continued with part B of the trial: zibotentan 1.5 mg plus dapagliflozin 10 mg/day and zibotentan ... The trial was funded by AstraZeneca. Some co-authors ...

The SGLT2 inhibitors, as a class, lead to similar treatment benefits at comparable clinical doses, although there are some discrepancies between them, particularly when dapagliflozin (Farxiga; ...